Mohammad RM - Search Results

1

Induction of apoptosis in breast cancer cells by TPA.

Li Y, Bhuiyan M, Mohammad RM, Sarkar FH. Li Y, et al. Among authors: mohammad rm. Oncogene. 1998 Dec 3;17(22):2915-20. doi: 10.1038/sj.onc.1202218. Oncogene. 1998. PMID: 9879997

2

Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.

Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A. Mohamed AN, et al. Among authors: mohammad rm. Oncogene. 1988 Oct;3(4):429-35. Oncogene. 1988. PMID: 3152600

3

Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.

Mohammad RM, Diwakaran H, Maki A, Emara MA, Pettit GR, Redman B, al-Katib A. Mohammad RM, et al. Leuk Res. 1995 Sep;19(9):667-73. doi: 10.1016/0145-2126(95)00037-o. Leuk Res. 1995. PMID: 7564478

4

The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.

Maki A, Diwakaran H, Redman B, al-Asfar S, Pettit GR, Mohammad RM, al-Katib A. Maki A, et al. Among authors: mohammad rm. Anticancer Drugs. 1995 Jun;6(3):392-7. doi: 10.1097/00001813-199506000-00005. Anticancer Drugs. 1995. PMID: 7670136

5

Effect of dolastatin 10 on human non-Hodgkin's lymphoma cell lines.

Maki A, Mohammad R, Raza S, Saleh M, Govindaraju KD, Pettit GR, al-Katib A. Maki A, et al. Anticancer Drugs. 1996 May;7(3):344-50. doi: 10.1097/00001813-199605000-00016. Anticancer Drugs. 1996. PMID: 8792010

6

Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.

Li Y, Mohammad RM, al-Katib A, Varterasian ML, Chen B. Li Y, et al. Among authors: mohammad rm. Leuk Res. 1997 May;21(5):391-7. doi: 10.1016/s0145-2126(96)00078-1. Leuk Res. 1997. PMID: 9225065

7

Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.

Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Pancreas. 1998 Jan;16(1):19-25. doi: 10.1097/00006676-199801000-00004. Pancreas. 1998. PMID: 9436858

8

An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.

Mohammad RM, Al-Katib A, Pettit GR, Vaitkevicius VK, Joshi U, Adsay V, Majumdar AP, Sarkar FH. Mohammad RM, et al. Clin Cancer Res. 1998 Apr;4(4):887-94. Clin Cancer Res. 1998. PMID: 9563882

9

Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.

Mohammad RM, Beck FW, Katato K, Hamdy N, Wall N, Al-Katib A. Mohammad RM, et al. Biol Chem. 1998 Oct;379(10):1253-61. doi: 10.1515/bchm.1998.379.10.1253. Biol Chem. 1998. PMID: 9820586

10

p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.

Wang H, Mohammad RM, Werdell J, Shekhar PV. Wang H, et al. Among authors: mohammad rm. Int J Mol Med. 1998 Jun;1(6):915-23. doi: 10.3892/ijmm.1.6.915. Int J Mol Med. 1998. PMID: 9852625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters